期刊
PREVENTIVE MEDICINE
卷 144, 期 -, 页码 -出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ypmed.2020.106399
关键词
-
资金
- Instituto de Salud Carlos III [PI18/01137]
- Secretariat for Universities and Research of the Department of Business and knowledge of the Government of Catalonia [SGR 2017-2019, 2017SGR1718, 2017SGR1085]
- European Union's Horizon 2020 research and innovation programme [847845]
The estimated global coverage of HPV vaccination from 2010 to 2019 is not high, with low- and middle-income countries showing relatively better progress. However, there is still a long way to go to achieve the 90% coverage target for HPV vaccination by 2030. Efforts should be made to maintain the pace of introductions and improve program performance globally, especially in the most populous countries.
WHO/UNICEF estimates for HPV vaccination coverage from 2010 to 2019 are analyzed against the backdrop of the 90% coverage target for HPV vaccination by 2030 set in the recently approved global strategy for cervical cancer elimination as a public health problem. As of June 2020, 107 (55%) of the 194 WHO Member States have introduced HPV vaccination. The Americas and Europe are by far the WHO regions with the most introductions, 85% and 77% of their countries having already introduced respectively. A record number of introductions was observed in 2019, most of which in low-and middle- income countries (LMIC) where access has been limited. Programs had an average performance coverage of around 67% for the first dose and 53% for the final dose of HPV. LMICs performed on average better than high- income countries for the first dose, but worse for the last dose due to higher dropout. Only 5 (6%) countries achieved coverages with the final dose of more than 90%, 22 countries (21%) achieved coverages of 75% or higher while 35 (40%) had a final dose coverage of 50% or less. When expressed as world population coverage (i.e., weighted by population size), global coverage of the final HPV dose for 2019 is estimated at 15%. There is a long way to go to meet the 2030 elimination target of 90%. In the post-COVID era attention should be paid to maintain the pace of introductions, specially ensuring the most populous countries introduce, and further improving program performance globally.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据